Fulbright Scholar
Children's Hospital of Philadelphia, USA; and Obafemi Awolowo University, Nigeria, Pennsylvania, United States
Disclosure information not submitted.
ILX-002 – A Direct HbS Polymerization Inhibitor for the Treatment of Sickle Cell Disease
Saturday, June 8, 2024
6:00 PM – 7:00 PM ET